Home NDC 55648-781 Entacapone
Product NDC 55648-781
11-digit product format 556480781
Labeler code 55648
Product ID 55648-781_db131736-7c7c-4f65-b2ee-b3d5f8e76ead
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Entacapone
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Wockhardt Limited
Application NDA020796
Marketing category NDA AUTHORIZED GENERIC
Marketing start 2012-09-30
Marketing end 0000-00-00
Substance ENTACAPONE
Active strength 200 mg/1
Pharmacologic classes Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC]
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 2 · 66 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020796-001 COMTAN ENTACAPONE 200MG TABLET / ORAL AB RLD, RS 1999-10-19
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N020796-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 c2088c7a36db…2026-09-14 22:38:34 2026-08 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 84e616aacf4f…2026-08-18 06:07:40 2026-07 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N020796-001 COMTAN 200MG TABLET / ORAL AB RLD, RS 1999-10-19 3a93d1ddd44b…
Observed Orange Book normalized TE history# Normalized TE history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2022-10-28 04:53 UTC 2022-10 N020796-001 AB 1 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N020796-001 AB 1 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N020796-001 AB 1 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N020796-001 AB 1 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 55648-781-02 Entacapone 1 in 1 CARTON TABLET, FILM COATED 1 1 55648-781-02 Entacapone 100 in 1 BOTTLE TABLET, FILM COATED 100 1 55648-781-03 Entacapone 500 in 1 BOTTLE TABLET, FILM COATED 500 1
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ENTACAPONE ACTIVE INGREDIENT 4975G9NM6T ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 1 ENTACAPONE ACTIVE MOIETY 4975G9NM6T ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 1 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 1 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 1 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 1 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 1 HYDROGENATED COTTONSEED OIL INACTIVE INGREDIENT Z82Y2C65EA ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 1 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 1 MANNITOL INACTIVE INGREDIENT 3OWL53L36A ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 1 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 1 SUCROSE INACTIVE INGREDIENT C151H8M554 ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 55648-781 ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 1 Legacy NDC, 3 package rows 20120930_5a68fa36-ed25-4309-8624-cd6a0001ec7f.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 55648-781-02 55648078102 1 in 1 CARTON Historical 55648-781-03 55648078103 500 in 1 BOTTLE Historical